Last reviewed · How we verify
Combined aspirin and multinutrient supplement
Aspirin reduces platelet aggregation and inflammation while multinutrients provide essential vitamins and minerals to support cardiovascular health and metabolic function.
Aspirin reduces platelet aggregation and inflammation while multinutrients provide essential vitamins and minerals to support cardiovascular health and metabolic function. Used for Cardiovascular disease prevention (phase 3 indication under investigation).
At a glance
| Generic name | Combined aspirin and multinutrient supplement |
|---|---|
| Sponsor | UMC Utrecht |
| Drug class | Antiplatelet agent combined with nutritional supplement |
| Target | COX-1/COX-2 (aspirin); multiple micronutrient targets (multinutrient component) |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, reducing thromboxane A2 production and platelet activation to prevent thrombotic events. The multinutrient component supplies cofactors and micronutrients (such as B vitamins, vitamin D, and minerals) that support endothelial function, homocysteine metabolism, and overall cardiovascular protection.
Approved indications
- Cardiovascular disease prevention (phase 3 indication under investigation)
Common side effects
- Gastrointestinal bleeding or ulceration
- Dyspepsia
- Bruising or minor bleeding
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: